Prognostic significance of β-catenin expression in patients with ovarian cancer: A meta-analysis

Gene. 2018 Dec 15:678:270-279. doi: 10.1016/j.gene.2018.08.047. Epub 2018 Aug 10.

Abstract

Aim: The purpose of this study was to evaluate the impact of β-catenin immunohistochemical expression on the prognostic of ovarian cancer (OC) for that β-catenin could be responsible for the development and progress of OC.

Methods: We searched various databases to identify eligible studies, and Review Managers 5.2 software was fulfilled in the meta-analysis.

Results: A total of 11 studies were defined and composed in 1858 cases. β-catenin expression was significantly correlated with poor overall survival (OS) in OC patients (HR: 2.48, 95% CI: 1.38-4.47, P = 0.003), and showed a significant degree of heterogeneity (I2 = 83%, P < 0.00001). Subgroup analysis indicated that accumulation in the nucleus and/or cytoplasm, rather than membrane, considerably influences the survival of OC patients independently.

Conclusion: Nucleus and/or cytoplasma of β-catenin expression might be associated with tumor progression and could be a possible potential predictive factor of poor prognosis in OC patients.

Keywords: Biomarker; Meta-analysis; Ovarian cancer; Prognosis; Survival; β-Catenin.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Cell Nucleus / metabolism
  • Cytoplasm / metabolism
  • Disease Progression
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoplasm Staging
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / pathology*
  • Prognosis
  • Survival Analysis
  • Up-Regulation*
  • beta Catenin / metabolism*

Substances

  • Biomarkers, Tumor
  • CTNNB1 protein, human
  • beta Catenin